Shiseido began manufacturing HA in 1984, and obtained the approval as the API for injections in 1993 in Japan. Since then, through numerous audits and inspections, we have been constantly improving our product quality and quality management system, as well as obtained approvals/registrations in the world. As a result, sales and supply volume have been expanding over 30 years and currently, we are supplying to more than 100 pharmaceutical companies across 30 countries.
: We have distributors in these areas (Europe, India, South Korea, Mexico, Russia)
On-going application for product registration in the Russian Federation